Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02169739 · ClinicalTrials.gov registry record · NA
Remote Preconditioning Over Time To Empower Cerebral Tissue
A NA study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02169739 is a NA study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 6 participants.
The verdict
NCT02169739, a NA study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Previous studies in animals and humans has shown that brief periods of reduced blood flow to one organ or tissue in the body can help protect other tissues from subsequent injury caused by reduced blood flow such as a stroke. This phenomenon is known as remote ischemic preconditioning and may help protect brain cells after a stroke. The investigators are studying a specific stroke type called subcortical stroke that is very common and has a high rate of recurrent stroke and cognition problems despite intensive prevention measures.
Interventions
- DEVICE Ischemic Preconditioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02169739
The ClinicalTrials.gov registry entry for NCT02169739 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ischemic Preconditioning is the first listed.
NCT02169739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02169739 about?
NCT02169739 is a clinical study titled "Remote Preconditioning Over Time To Empower Cerebral Tissue". Previous studies in animals and humans has shown that brief periods of reduced blood flow to one organ or tissue in the body can help protect other tissues from subsequent injury caused by reduced blood flow such as a stroke. This phenomenon is known as remote ischemic preconditioning and may help p...
What is the current status of trial NCT02169739?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2015-11. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02169739?
The interventions under investigation include: Ischemic Preconditioning (DEVICE).
Who is sponsoring clinical trial NCT02169739?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.